Ameriprise’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,740
Closed -$270K 4089
2022
Q3
$270K Buy
+25,740
New +$282K ﹤0.01% 3614
2020
Q4
Sell
-49,177
Closed -$445K 3848
2020
Q3
$445K Sell
49,177
-15,294
-24% -$223K ﹤0.01% 3284
2020
Q2
$1.77M Sell
64,471
-21,778
-25% -$593K ﹤0.01% 2672
2020
Q1
$1.9M Buy
86,249
+9,072
+12% +$291K ﹤0.01% 2506
2019
Q4
$2.91M Sell
77,177
-8,184
-10% -$305K ﹤0.01% 2537
2019
Q3
$2.63M Buy
85,361
+5,251
+7% +$176K ﹤0.01% 2566
2019
Q2
$3.16M Sell
80,110
-2,756
-3% -$96.9K ﹤0.01% 2509
2019
Q1
$3.2M Buy
82,866
+45,758
+123% +$1.07M ﹤0.01% 2504
2018
Q4
$875K Buy
+37,108
New +$1.07M ﹤0.01% 2991

Other funds holding TCDA

Ameriprise's TCDA Position: Q4 2022 in Review

Ameriprise sold out of Tricida, Inc. Common Stock (TCDA) in Q4 2022, closing a stake of 25,740 shares — an estimated $270K sold.

Ameriprise first reported a position in TCDA in Q4 2018 and held it in 9 quarters. The position peaked at $3.2M in Q1 2019. 70 funds tracked by Wall St. Rank hold TCDA as of Q4 2022.

  • Ameriprise reported no remaining Tricida, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ameriprise sold 25,740 Tricida, Inc. Common Stock shares in Q4 2022, an estimated $270K.
  • Ameriprise first reported a position in Tricida, Inc. Common Stock in Q4 2018 and held it in 9 quarters.
  • Ameriprise's Tricida, Inc. Common Stock position peaked at $3.2M in Q1 2019.
  • 70 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.